The Magazine for Sleep Professionals
Saturday, August 29, 2026
Avadel Pharmaceuticals plc announced that the U.S. Food & Drug Administration (FDA) has granted final approval to LUMRYZ, an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. With final approval, LUMRYZ becomes […]
SunMed, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care, today announced the completion of its acquisition of Vyaire Medical’s (“Vyaire”) business unit that manufactures and markets respiratory and anesthesia consumables. Through the combination, SunMed is creating a leading manufacturer wholly dedicated to […]
AdaptHealth LLC, formerly known as QMES, LLC, a provider of durable medical equipment based in Plymouth Meeting, Pennsylvania, will pay $5.3 million to resolve alleged False Claims Act violations for submitting allegedly false claims to federal healthcare programs for respiratory devices that patients did not need or use, in violation […]
According to a March 2023 survey commissioned by the American Academy of Sleep Medicine, one-third of adults (32%) “always or often” lose sleep at night due to worries about environmental issues. The survey found that younger generations are more likely to experience this problem, with 41% of Generation Z and 37% of millennials […]
Sleep Solutions, a regional medical equipment company based in Detroit that specializes in sleep and respiratory care, just completed a trial of 100 patients beginning CPAP. Of those, 50 patients received standard care, and 50 patients received standard care with the V̇-Com™ device (SleepRes, LLC, Murfreesboro, TN) in their CPAP […]
Pear Therapeutics, Inc. announced that the Company and its wholly owned subsidiary, Pear Therapeutics (US), Inc. (collectively, the “Debtors”), each voluntarily filed for protection under chapter 11 (“Chapter 11”) of the U.S. Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy […]
Nox Medical has secured a new patent to measure breathing movements for determining endophenotypes of sleep-disordered breathing using Nox RIP technology. The Patent No. US 11,602,282 B2 describes how the signals measured from Nox respiratory effort bands (RIP) can be used to derive information on internal respiratory effort mechanisms. This […]
Onera Health announced an exclusive strategic partnership with MedBridge Healthcare, a provider of sleep management services including sleep screening, in-center, inpatient and home diagnostic testing and therapy coordination. This new partnership aims to broaden access to Onera’s medical-grade PSG-as-a-Service solution, further improving the patient experience and lowering the operational burden […]
Nox Health has joined the American Heart Association Center for Health Technology & Innovations (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions. The Innovators’ Network is a healthcare technology consortium that connects entrepreneurs, providers, researchers and payers. Innovators’ […]
